David J. Maloney
Gründer bei Veralox Therapeutics, Inc.
Profil
David J.
Maloney is the founder of Veralox Therapeutics, Inc. (founded in 2017) where he holds the title of Chief Scientific Officer.
In 2017, he worked as Vice President & Head-Translational Medicine at Rebus Holdings, Inc. Dr. Maloney holds a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
Aktive Positionen von David J. Maloney
| Unternehmen | Position | Beginn |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Gründer | 01.01.2017 |
Ehemalige bekannte Positionen von David J. Maloney
| Unternehmen | Position | Ende |
|---|---|---|
| REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01.12.2017 |
Ausbildung von David J. Maloney
| University of Virginia | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
